3,5-dihydroxyphenylglycine has been researched along with methionine in 1 studies
Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (methionine) | Trials (methionine) | Recent Studies (post-2010) (methionine) |
---|---|---|---|---|---|
301 | 1 | 61 | 27,485 | 530 | 5,020 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Base, CK; Bertaina-Anglade, V; de Vries, FE; Greenough, WT; Grossman, AW; Hatia, F; Khaliq, H; Kim, SH; Klintsova, AY; Lambers, FA; Spangler, CC; Weiler, IJ | 1 |
1 other study(ies) available for 3,5-dihydroxyphenylglycine and methionine
Article | Year |
---|---|
Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.
Topics: Animals; Fragile X Mental Retardation Protein; Gene Deletion; Glycine; Methionine; Mice; Mice, Knockout; Microscopy, Electron; Nerve Tissue Proteins; Neurotransmitter Agents; Potassium; Protein Biosynthesis; Resorcinols; Ribosomes; RNA-Binding Proteins; Synapses | 2004 |